fda warning glp-1 compounding september 2025 Congress Introduces SAFE Drugs Act of 2025, Expanding Oversight of Compounded Drugs and Telehealth Providers FDA unleashes warning letters to

Flexibility and Mobility Work Limited hip flexibility increases adductor strain risk by forcing the muscles to work through inadequate range of motion

1 in 8 people are now using GLP-1 medications

Lipid peroxidation and antioxidants as biomarkers of tissue damage

And here's where things get interesting

Ricinus Communis (Castor) Seed Oil, Caprylic/Capric Triglyceride, Vegetable Oil\Olus Oil\Huile Vgtale, Euphorbia Cerifera (Candelilla) Wax\Candelilla Cera\Cire De Candelilla, Beeswax\Cera Alba\Cire D'Abeille, Ozokerite, Hydrogenated Vegetable Oil, Butyrospermum Parkii (Shea) Butter, Simmondsia Chinensis (Jojoba) Seed Oil, Barium Sulfate, Tocopherol, Butyrospermum Parkii (Shea) Butter Extract, Mangifera Indica (Mango) Seed Butter, Limnanthes Alba (Meadowfoam) Seed Oil, Helianthus Annuus (Sunflower) Seed Oil, Olea Europaea (Olive) Fruit Oil, Benzyl Alcohol, [+/- Mica, Titanium Dioxide (CI 77891), Iron Oxides (CI 77491), Iron Oxides (CI 77492), Iron Oxides (CI 77499), Bismuth Oxychloride (CI 77163), Bronze Powder (CI 77400), Copper Powder (CI 77400), Manganese Violet (CI 77742), Orange 5 (CI 45370), Red 6 (CI 15850), Red 7 (CI 15850), Red 21 (CI 45380), Red 27 (CI 45410), Red 30 (CI 73360), Blue 1 Lake (CI 42090), Red 7 Lake (CI 15850), Red 22 Lake (CI 45380), Red 28 Lake (CI 45410), Red 30 Lake (CI 73360), Red 33 Lake (CI 17200), Yellow 5 Lake (CI 19140), Yellow 6 Lake (CI 15985)]

Faubert, B., Solmonson, A